Ganaxolone is a synthetic neuroactive steroid and a positive allosteric modulator of GABAA receptors that acts at sites distinct from benzodiazepines. Approved for the treatment of seizures associated… Read more
![Chemical structure of 1-((3R,5S,8R,9S,10S,13S,14S,17S)-10,13-Dimethylhexadecahydrospiro[cyclopenta[a]phenanthrene-3,2'-oxiran]-17-yl)ethan-1-one](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F148256-45-5-1-3R5S8R9S10S13S14S17S-1013-Dimethylhexadecahydrospirocyclopentaaphenanthrene-32-oxiran-17-ylethan-1-one.png&w=3840&q=75)
![Chemical structure of 1-((3S,5S,8R,9S,10S,13S,14S,17S)-3-Hydroxy-3,10,13-trimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)ethan-1-one](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1264737-31-6-1-3S5S8R9S10S13S14S17S-3-Hydroxy-31013-trimethylhexadecahydro-1H-cyclopentaaphenanthren-17-ylethan-1-one.png&w=3840&q=75)
![Chemical structure of 1-((5S,8R,9S,10S,13S,14S,17S)-3,10,13-Trimethyl-4,5,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)ethan-1-one](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1-5S8R9S10S13S14S17S-31013-Trimethyl-4567891011121314151617-tetradecahydro-1H-cyclopentaaphenanthren-17-ylethan-1-one.png&w=3840&q=75)
![Chemical structure of 1-((8R,9S,10S,13S,14S,17S)-10,13-Dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)ethan-1-one](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F32695-80-0-1-8R9S10S13S14S17S-1013-Dimethylhexadecahydro-1H-cyclopentaaphenanthren-17-ylethan-1-one.png&w=3840&q=75)
![Chemical structure of 2-((3R,5S,8R,9S,10S,13S,14S,17S)-3-Hydroxy-3,10,13-trimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl L-valinate Hydrochloride](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2379819-18-6-2-3R5S8R9S10S13S14S17S-3-Hydroxy-31013-trimethylhexadecahydro-1H-cyclopentaaphenanthren-17-yl-2-oxoethyl-L-valinate-Hydrochloride.png&w=3840&q=75)



Ganaxolone is a synthetic neuroactive steroid and a positive allosteric modulator of GABAA receptors that acts at sites distinct from benzodiazepines. Approved for the treatment of seizures associated with specific rare genetic disorders, this experimental agent has demonstrated efficacy across a range of epilepsy models. Laboratories utilize high-quality ganaxolone reference standards, including the active pharmaceutical ingredient and related analytical markers, to support critical quality control and method validation processes. Our collection includes pharmacopeial and non-pharmacopeial impurities, potential metabolites, and stable isotope-labelled compounds, such as deuterated analogues. These materials are essential for accurate impurity profiling, supporting the development of robust analytical methods and ensuring the precise quantification of trace components during stability testing and pharmaceutical research. Researchers rely on these well-characterized standards to maintain compliance and consistency throughout the drug development lifecycle.